STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be ...

April 3 (Reuters) - Karolinska Development AB: * KAROLINSKA-REPORTED TOP-LINE DATA FROM CLINICAL PHASE 2A STUDY OF DRUG CANDIDATE GOLEXANOLONE IN PATIENTS AT RISK OF DEVELOPING HEPATIC ENCEPHALOPATHY ...

In a Phase 2a clinical trial, imdusiran achieved meaningful functional cure rates in patients with cHBV when combined with pegylated interferon (IFN) alfa-2α and nucleos (t)ide analogue (NA) therapy.

In a late-breaker poster presentation, the following select key end-of-study data were reported from the Phase 2a clinical trial (IM-PROVE II, AB-729-202) evaluating stable nucleos (t)ide analogue ...

Results from a Phase 2a study of MAR001 demonstrated clinically meaningful reductions in remnant cholesterol and triglycerides. Marea plans to advance MAR001 into Phase 2b clinical development in ...

“We are excited to share significant findings from the post hoc analysis of the phase 2a clinical trial of ENV-101, highlighting our pulmonary vessel volume quantification model, Vascul8 ...

Outlook Management reiterated expectations for interim results from the ABS-101 Phase I trial in the second half of this year. For ABS-201, first-in-human trials are planned for early 2026, with ...

It also develops LIB-01 until clinical phase 2a and then accelerate and finance the drug development further together with pharma partners into a registered drug for the world market.